巨大肝癌的外科治疗:附146例报告
作者:
通讯作者:
作者单位:

作者简介:

基金项目:


Surgical treatment for giant primary liver cancer: a report of 146 cases
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:探讨巨大肝癌外科治疗的效果。方法:回顾性分析近11年间收治的146例原发性巨大肝癌的外科治疗情况。146例均经手术治疗,其中行不规则肝切除99例,半肝切除28例,右三叶切除4例,包括术前行TACE后获得二期切除19例;6例同时行门静脉切开取栓术。另15例仅行活检+DDS,术中行DDS治疗者105例。 结果:手术并发症发生率10.3%, 术后1个月内病死率1.4%, 术后1,3,5年和10年的生存率分别为56.6%,30.2%, 14.4% 和2.1%。 结论:巨大肝癌仍以手术切除为主,疗效满意。结合TACE、门静脉取栓和DDS能提高患者的远期生存率。

    Abstract:

    Objective:
    To investigate the effect of surgical treatment for giant primary liver cancer.Methods:One hundred and fortysix cases of giant primary liver cancer received surgical treatment in recent 11 years ware analyzed retrospectively. Of them, 99 cases underwent irregular hepatectomy ,28 hemihepatectomy and 4 right hepatic trisegmentectomy .Including 19 cases received secondary resection after preoperative TACE,meanwhile 6 cases were underwent portal venous cancer thrombus extraction, 15 cases received biopsies and DDS only, Interoprative DDS
    were performed in 105 cases. Result:The postoperative complications was 10.3%, the postoperative mortality was 1.4%.The 1-,3-,5- and 10year survival rates were 56.6%, 30.2% ,14.4% and 2.1% respectively. Conclusions: The main treatment of giant liver cancer is hepatcctomy.Combination with TACE,portal thrombus extraction and DDS can improve the longterm survival.

    参考文献
    相似文献
    引证文献
引用本文

江献川,娄尧强, 彭淑牖.巨大肝癌的外科治疗:附146例报告[J].中国普通外科杂志,2004,13(3):2-166.
DOI:10.7659/j. issn.1005-6947.2004.03.002

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2004-03-25